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ABSTRAK 
KAJIAN PROSPEKTIF DIKALANGAN PESAKIT SURGERI YANG 
MENGALAMI TROMBOSIS PADA VENA DALAM SECARA “SENYAP” DI 
HOSPITAL UNIVERSITI SAINS MALAYSIA 
Pengenalan: Trombosis vena dalam berbentuk senyap adalah salah satu komplikasi yang 
mengancam nyawa pesakit-pesakit surgeri. Setakat ini, hanya satu kajian yang telah 
melaporkan kes-kes baru (insiden) thrombosis pada vena secara senyap  di Malaysia. Selain 
daripada itu, tiada usaha setakat ini untuk menilai penggunaan model penilaian risiko 
Caprini untuk mengenalpasti subjek yang memerlukan pencegahan thrombosis pada vena 
dalam secara senyap (DVT). 
Objektif: Tujuan kajian ini adalah untuk menentukan insiden trombosis vena dalam secara 
“senyap” dan menilai potensi kepenggunaan model penilaian risiko Caprini dalam 
mengenalpasti pesakit yang memerlukan pencegahan DVT. 
Metodologi: Ini adalah kajian prospektif kohort yang melibatkan 55 orang pesakit surgeri 
di HUSM yang mempunyai risiko tinggi untuk mengalami thrombosis vena dalam secara 
senyap. Setiap subjek telah menjalani pemeriksaan ultrabunyi dupleks bagi sistem vena 
dalam sebelum dan selepas pembedahan yang dijalankan oleh dua orang pakar radiologi. 
Skor risiko Caprini dikira untuk setiap subjek dan pemberian pencegahan DVT 
kemudiannya dibuat berdasarkan keputusan pakar klinikal yang bertanggungjawab terhadap 
pesakit tersebut, yang tidak mengetahui skor risiko Caprini. Hubungkait antara skor risiko 
Caprini dan pemberian pencegahan DVT di analisa secara statistik dengan menggunakan 
xii 
 
kaedah regressi linear dan logistic mudah. Nilai p yang kurang daripada 0.05 dianggap 
mempunyai kesan yang ketara dari segi analisa statistik. 
Keputusan:  Tiada subjek mengalami trombsis vena dalam (kadar insiden = 0% (n=0) ). 
Terdapat hubungkait yang ketara antara pencegahan DVT dan skor Caprini (nisbah ganjil 
8.16 (95% selang keyakinan: 1.01, 68.74), nilai p = 0.016). Selain itu, penggunaan keteter 
vena utama juga mempunyai hubungkait yang ketara dengan pencegahan DVT (nisbah 
ganjil 6.34  (95% selang keyakinan 1.62, 24.80), nilai p = 0.008). Menariknya, penggunaan 
keteter pada vena utama menyebabkan peningkatan skor risiko Caprini sebanyak 4 unit 
(purata kenaikan : 4.186 (95% selang keyakinan 3.164, 5.207, nilai p <0.001) berbanding 
sebanyak 2 skor yang pada kebiasaannya diberikan terhadap faktor risiko ini. 
 Kesimpulan: Trombosis pada vena dalam secara “senyap” secara nyatanya  tidak wujud 
dalam kajian ini. Penggunaan pencegahan DVT secara berhemat yang berpandukan 
penggunaan skor risiko Caprini secara tidak langsung sepanjang praktis klinikal harian 
mungkin boleh menerangkan ketiadaannya thrombosis pada vena dalam secara “senyap” 
semasa kajian ini. Walaubagaimanapun, kajian lanjut adalah diperlukan untuk 
mempercirikan penggunaan skor risiko Caprini untuk meramalkan kewujudan thrombosis 
vena dalam secara “senyap” di persekitaran kajian ini. 
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ABSTRACT 
A PROSPECTIVE OBSERVATIONAL STUDY ON POST-OPERATIVE MAJOR 
SURGICAL PATIENTS DEVELOPING SILENT DEEP VEIN THROMBOSIS AT 
HOSPITAL UNIVERSITI SAINS MALAYSIA 
Introduction: Silent deep vein thrombosis (DVT) is one of the life-threatening 
complications affecting surgical patients. So far there is only one study documenting the 
incidence of silent DVT in Malaysia. Besides, no efforts have been made to evaluate the 
use of Caprini risk assessment model to identify subjects who are in need of prompt DVT 
prophylaxis. 
Objectives:  The aims of this study are to determine the incidence of silent DVT and 
evaluate the potential utility of Caprini risk assessment model to target high risk subjects 
for DVT prophylaxis. 
Methods: This is a prospective cohort study involving 55 HUSM surgical subjects who are 
at risk of silent DVT. Each subject had a preoperative and postoperative compression 
ultrasound complemented by duplex venous ultrasonography of deep venous system 
performed by two separate radiologists. Caprini risk assessment scores were calculated for 
each study participants and the decision on the administration of DVT prophylaxis was 
made based on the clinical judgement of the clinicians in charge without knowing the 
calculated Caprini risk scores. The association between DVT prophylaxis and Caprini risk 
scores were analysed using simple logistic regression. Any p value that is less than 0.05 is 
considered statistically significant. 
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Results: Not a single subject developed DVT (incidence rate of silent DVT = 0%, n=0). 
There is a significant association between DVT prophylaxis and Caprini risk scores (OR 
8.16 (95% CI: 1.01, 68.74),  p value = 0.008). Besides, the use of central venous catheter is 
also significantly associated with the use of DVT prophylaxis (OR 6.34 (95% CI: 1.62, 
24.80), p value = 0.016). Interestingly the use of central venous catheter resulted in more 
than 4 point increment of Caprini risk scores (mean increment: 4.186 (95% CI: 3.164, 
5.207), p value <0.001) instead of the usual 2 points allotted to this risk factor. 
Conclusion: Silent DVT is virtually non-existent in this study setting. The judicious use of 
DVT prophylaxis, which is guided by the inadvertent use of Caprini risk score during day-
to-day practice, may explain the effective prevention of silent DVT at this setting. 
Nevertheless, further studies are warranted to further characterize the utility of Caprini risk 
assessment scores for the prediction of silent DVT in this setting. 
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CHAPTER ONE 
INTRODUCTION 
1.1  SCIENTIFIC BACKGROUND OF VENOUS THROMBOEMBOLISM 
Venous thromboembolism imposed a great impact on the mortality of the 
surgical and medical patients. It is the most preventable cause of death in surgery. 
Venous thromboembolism is a broad term used to describe deep vein thrombosis and 
also pulmonary embolism. The natural history of venous thromboembolisms are 
resolution, propagation, recanalization and embolization. The pathogenesis of venous 
thromboembolism is multifactorial. Up to date, there is still no single independent 
predicting factors that have a direct relationship with increase occurrence of deep vein 
thrombosis. Rudolf Virchow, a German Pathologist, made famous as the Father of 
Pathologist in his era postulated the pathogenesis of the formation of thrombus through 
the classical Virchow’s triad: endothelial injury, blood stasis and hypercoagulability. 
With the presence of any of the components in the triad, there would be increased risk 
of thrombus formation. Efforts have been made over the years to study its pathogenesis 
and also to device a tool to predict its coming and outcome. Post-operative venous 
thromboembolism is reported as one of the most preventable hospital morbidity and 
mortality in today’s practice of the anti-thomboprophylaxis agent.  
 
1.2  EPIDEMIOLOGY OF DEEP VEIN THROMBOSIS 
In an International Multicentre trial on antithrombotic prophylaxis, they 
documented the clinical deep vein thrombosis in post-operative period to be as high as 
31% (211/667) whilst in those with prophylaxis heparin is 8.5% (53/667). They also 
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reported that the time of onset of the clinical deep vein thrombosis is highest from the 
third to the sixth days post operative period in both control and heparinized groups 
(Kearon, 2003; Kakkar et al., 1975). Wilasusmee et al. (2009) reported the prevalence 
of 10.5% of their patients admitted to ICU with presence of deep vein thrombosis and in 
this setting, the investigators did not give routine thromboprophylaxis to all their 
patients. Chua et al. (2008) reported an incidence of 5.01% (21/251) for clinical deep 
vein thrombosis among admissions for neuro-rehabilitation (median of 14 days post-
events) in a Singaporean setting.  They used D-Dimer assay as the markers to select the 
groups of patient going for Duplex venous ultrasound scan. From their 251 patients, 
they have 247 patients who have elevated D-Dimer assay of more than 0.34µg/mL and 
among these patients; only 21 patients have positive findings of deep vein thrombosis at 
either proximal or distal deep vein systems. Therefore, they concluded that in asian 
neurorehabilitation admission in Singapore, the asymptomatic lower limb DVT is 
uncommon with the possible genetic or ethnic protective factors, early walking 
initiation and the timing of the admission which is during the decline of the maximal 
thrombotic risk (Chua et al., 2008).  
In United States, the deep vein thrombosis is affecting about 145 per 100,000 
individuals per year whilst the pulmonary embolism reported as 69 per 100,000 
individuals per year in the general population (Caprini and Arcelus, 2006; Silverstein et 
al., 1998). The venous thromboembolism accounted for 150,000 to 200,000 deaths per 
year and one third of the venous thromboembolism related deaths occur following 
surgery (Gould et al., 2012).  
In 2007, the epidemiological model was constructed to estimate the number of 
venous thromboembolism per annum within the six European Union countries; France, 
Germany, Italy, Spain, Sweden and United Kingdom. The estimated symptomatic 
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venous thromboembolism events per annum was 465,715 cases of deep vein 
thrombosis, 295,982 cases of pulmonary embolism and 27,473 venous 
thromboembolism related deaths (Cohen et al., 2007).  
In an American study by Harris et al. (1997), they screened for asymptomatic 
deep vein thrombosis in surgical intensive care patients. They yield an incidence of 
7.5% of proximal deep vein thrombosis which is asymptomatic. Based on the natural 
history of the proximal deep vein thrombosis, 40% of asymptomatic deep vein 
thrombosis will become symptomatic and the rest remain undiagnosed. From the 
undiagnosed thrombosis, 50% will develop pulmonary embolism and 30% will 
succumb to the disease (Harris et al., 1997).  
In the United Kingdom, it has been reported in 2005 through The House of 
Commons Health Committee that an estimation of 25,000 deaths resulted from 
preventable hospital-acquired venous thromboembolism per year (NICE, 2010). 
Prophylaxis was concluded to be underuse. However, most of the study subjects are 
Caucasian, it would only be unfair to extrapolate their epidemiology to the Asian. 
There is a similar study conducted in our hospital in 2004 looking at the 
incidence of deep vein thrombosis in post operative general surgery patients. All the 
study subjects were not given any forms of thromboprophylaxis as it was not within the 
hospital policy and it was strongly believed that the Asian has a low incidence of 
developing deep vein thrombosis by the treating clinicians. From their results, they 
noted an incidence of 2.2 percent which is comparatively low when compared to the 
Caucasion populations (Tun et al., 2004). 
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1.3 SILENT DEEP VEIN THROMBOSIS 
Silent deep vein thrombosis also known as asymptomatic deep vein thrombosis 
is formation of thrombus within the deep vein system with no clinical manifestations 
such as the swollen tender limbs seen in symptomatic deep vein thrombosis. In the 
thrombosis research efforts were made in detection of early thrombus formation in the 
attempt to halt the propagation of the thrombus that may eventually lead to venous 
thromboembolic event such as pulmonary embolism. Repeated statements were made 
over the years that venous thromboembolism is the most preventable hospital morbidity 
and mortality. Hence, strong advocation for the usage of thromboprophylaxis especially 
from the pharmacological giants. However, not all the centres have the financial luxury 
to supply the thromboprophylaxis agents to all the patients. Hence, it driven the effort of 
my study to detect silent deep vein thrombosis in an effort to justify the use of 
thromboprophylaxis agents either it is a mechanical or pharmacological agents.  
 
1.4 CAPRINI RISK ASSESSMENT SCORES 
The venous thromboembolism is a common cause of preventable death in 
surgical patients (Gould et al., 2012). Efforts have been made over the years to reduce 
the risk and prevent the venous thromboembolism. There are multiple risk assessment 
models proposed over the years to risk stratify the patients. My predecessors were using 
Salzman and Hirsh predictive models (Salzman and Hirsh, 1994; Tun et al., 2004) in the 
risk stratifications of their patients. However, I found that it is lack of details and the 
stratification may occasionally become a subjective overview of the patient’s risk, 
hence, leading to bias of risk stratifications. I choose to use Caprini Risk Assessment 
Model as it is more clinician friendly and less burden when applied at a busy referral 
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centre such as ours. It is simple scoring systems which can be performed by just ticking 
the boxes by the house officers on admissions. Knowing the risks enable us to be more 
vigilant in the preventive efforts. 
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CHAPTER TWO 
LITERATURE REVIEW 
The post operative patients have significant increase risk of Deep Vein 
Thrombosis (DVT) due to late mobilization or exposure to thrombin generating 
procedures such as central venous catheterization and surgical procedures. Most of the 
epidemiological data regarding silent and clinical venous thromboembolisms are 
reflective of the western population. There are scanty data on our region to support and 
justify the use of anti-thromboprophylaxis agents in our post operative patients.  
Most of the studies are focused on clinical venous thromboembolism. However, 
little was done to detect silent or asymptomatic venous thromboembolism. It may be 
due to the unawareness of the impact that silent deep vein thrombosis to the financial 
burden of our health care system. Silent deep vein thrombosis may resolve 
spontaneously or may progress to symptomatic DVT and life threatening Pulmonary 
Embolism (PE). It is the most preventable death in post-operative surgical patients. 
Deep vein thrombosis is the formation of thrombus within the deep vein system 
of the lower limbs which manifest clinically as painful and swollen calf. Silent Deep 
Vein Thrombosis is defined as the formation of thrombus within the deep vein system 
of the lower limbs without any clinical manifestations. It is also described in the 
literature as asymptomatic deep vein thrombosis. Venous Thromboembolism imposes a 
great morbidity and mortality to post operative patients. It is the most preventable 
mortality in surgical patients (Gould et al., 2012). 
In a Japanese prospective clinical trial, they observed the incidence of 
asymptomatic deep vein thrombosis to peak on the post operation day 4. In their study, 
they have recruited 101 patients undergoing either total hip or knee replacement 
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surgery. All their patients received prophylactic injection of Fondaparinux on the post 
operation day 1 onwards up to day 14. They noticed in the total hip replacement surgery 
group, the incidence of the asymptomatic deep vein thrombosis was 0% on the day of 
surgery, 13.6% on day 1, 27.1% at day 4 and 11.9% at day 14. In the total knee 
replacement group, they noticed the incidence of asymptomatic deep vein thrombosis 
was 50% on day 1, 58.3% at day 4 and 20.8% at day 14 (Yamaguchi et al., 2010). In 
our daily observations, most of our patients undergoing major abdominal surgery are 
discharged at the average of post operation day 4. Hence, we arranged for the ultrasound 
duplex of the venous system on day 4 or on the day before their discharge. 
The Venous duplex ultrasound with venous compression ultrasonographic 
assessment is used to detect the deep vein thrombosis. Although the sensitivity of the 
above examination is still debatable and controversial in terms of detecting 
asymptomatic deep vein thrombosis, it is still the easiest and least invasive compared to 
the contrast venography (Quenet et al., 2012). The compression ultrasonography is 
highly accurate method for detecting proximal deep vein thrombosis with slightly poor 
sensitive in detecting calf deep vein thrombosis (Jongbloets et al., 1994). The sensitivity 
and specificity of compression ultrasonography in detecting proximal deep vein 
thrombosis reported as 91% and 99%, respectively (Lensing et al., 1989; Weinmann 
and Salzman, 1994). Contrast venography is sensitive and specific to detect DVT. 
However, it imposes the patients to the risks to contrast related side effects and may not 
be possible in several groups of surgical patients (Jongbloets et al., 1994).  
Bilateral ultrasonography of the lower extremity is performed with colour flow 
duplex imaging of the major proximal veins including the common femoral, superficial 
femoral and popliteal veins. The routine used probes are the linear probes of 9-3MHz or 
curved probes of 5-2MHz. The compressibility is evaluated at 1cm intervals. The 
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diagnosis of deep vein thrombosis is deemed when the venous segment was not fully 
compressible, the presence of thrombus in the vein, absence of flow or abnormal 
flow.(Harris et al., 1997, Pennell et al., 2008, Kume et al., 2010) 
 
2.2 A BRIEF COMPARISON ON VARIOUS TYPES OF DVT RISK 
STRATIFICATION SYSTEMS 
 So far, only one local study which utilized DVT risk stratification systems for  
the selection of study subjects (Tun et al., 2004). The investigators utilized the modified 
version of Salzman and Hirsh (Salzman and Hirsh 1994) for risk stratifying subjects 
who were at risk of DVT. This system classified to three risk strata (low, moderate and 
high risk groups) based on the age of the subjects, types and duration of surgery, 
medical comorbidities (major or minor medical illnesses), presence of lower limb 
paralysis and lower limb amputation. However, this risk-stratification system is overly 
simplified since it excludes other significant DVT risk factors such as family history of 
thrombophilia, specific types of surgery and others. Besides, the stratification system is 
also too subjective which makes it operator-dependant. This will result in variable 
predictive outlook given to the same subset of subjects by different operators. 
Consequently, Salzman and Hirsh’s risk stratification system becomes a less accurate 
tool for predicting the occurrence of DVT in general surgical setting. The full details on 
Salzman and Hirsh’s DVT risk classification system is summarized in figure 2.1. 
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Figure 2.1:  Modified version of Salzman and Hirsh’s risk stratification system for 
DVT based on Tun et al. (2004). 
 Deep Vein Thrombosis Fatal Pulmonary Embolism 
Low risk groups 
Moderate risk groups 
High risk groups 
<10% 
10-40% 
40-80% 
0.01% 
0.1-1% 
1-10% 
Low risk groups Minor surgery (<30 min); no risk factor other than age 
groups 
Major surgery (>30 min); age <40 years; no other risk 
groups 
Minor trauma or medical illness 
Moderate risk groups Major general, urological, gynaecological, cardiothoracic, 
vascular or neurological surgery; age >40 years or other 
risk factors 
Major medical illness, heart or lung disease or cancer, 
inflammatory bowel disease 
Major trauma or burns 
Minor surgery, trauma or illness in patients with previous 
deep vein thrombosis, pulmonary embolism or 
thrombophilia 
High risk groups Fracture or major orthopaedic surgery of pelvis, hip or 
lower limb 
Major pelvic or abdominal surgery for cancer 
Major surgery, trauma or illness in patients with previous 
deep vein thrombosis, pulmonary embolism or 
thrombophilia 
Lower limb paralysis (hemiplegia, stroke or paraplegia) 
Major lower limb amputation 
       (Tun et al., 2004, with permission)
 To address the weaknesses of  Salzman and Hirsh’s system, another competing 
DVT risk stratification system was developed. Caprini’s risk assessment model was 
originally developed in 1991 by a group of researchers from Northwestern University 
(Arcelus et al.  1991). The investigators classified the risks associated with DVT into 
two broad categories; primary (mostly inherited deficiencies or disorders of key players 
in coagulation systems, for instance antithrombin III deficiency, disorders associated 
with plasminogen, dysfibrinogenemia and others) and secondary risk factors (old age, 
use of oral contraception, malignant diseases, pregnancy and others). As the knowledge 
of the pathophysiological process of DVT burgeons, Caprini’s risk assessment model 
for DVT  was revised and upgraded, culminating in an improved version called 
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Caprini’s risk assessment model version 2005 (Caprini 2005). This new, upgraded 
version of Caprini’s risk assessment model has been validated in various surgical 
settings such as general surgery and plastic and reconstructive surgery, for the 
prediction of 30 and 60-day mortality secondary to deep vein thrombosis and these 
studies found that the Caprini’s risk assessment model accurately predicted the 
development DVT in both general and plastic and reconstructive surgical populations 
(Bahl et al., 2010, Pannucci et al., 2011). Nevertheless, this DVT risk stratification 
system received a further upgrade when Caprini (2010) published the 3rd version of the 
Caprini’s risk assessment model. The differences between the 2nd and 3rd version of the 
DVT risk stratification tool is summarized in figure 2.2 (adapted from Pannucci et al., 
2012). 
Figure 2.2: Comparison between the 2nd and 3rd version of Caprini’s risk assessment 
models 
 2005 Caprini Model 
 
 2010 Caprini Model 
Operative 
Time 
0-44 min 
≥ 45 min 
1 point 
2 points 
0-59 min 
60-119 min 
120-179 min 
≥ 180 min 
1 point 
2 points 
3 points 
5 points 
Body Mass 
Index 
(kg/m2) 
≥25 1 point ≥30 and <40 
≥40 and <50 
≥50 
1 point 
2 points 
3 points 
SVT Not as risk 
factor 
- History of SVT 3 points 
Cancer History of 
cancer 
Current cancer 
2 points 
2 points 
History of cancer  
Current cancer 
2 points 
3 points 
 
Issues have been raised about which of the versions fare better in terms of 
accurately stratifying the subjects who are at risk of developing DVT. To provide 
definite answers to this information lacuna, Pannucci and associates (2012) validated 
both versions of Caprini’s risk assessment model in a surgical setting. The authors 
found that the 2005 version of Caprini’s risk assessment model is the better tool in 
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identifying subjects who are at increased risk of DVT. As a result, it is now gaining a 
rapid rise in popularity due to its simplicity (it is in a checklist format), excellent 
validity, and high applicability across the multitude of surgical disciplines. 
Nevertheless, no local studies so far have endeavoured to assess the validity of the 
Caprini’s risk assessment model for DVT risk stratification. Therefore, an attempt to do 
so is therefore highly applaudable. 
 
2.3 JUSTIFICATION OF THE STUDY 
The venous thromboembolism is a common cause of preventable death in 
surgical patients (Gould et al., 2012). Efforts have been made over the years to reduce 
the risk and prevent the venous thromboembolism. There are multiple risk assessment 
models proposed over the years to risk stratify the patients. The simplest being a 
classification by Clagett et al. (1988) who classified the level of venous 
thromboembolism risk to low, moderate, high and highest. This classification is lack of 
details hence, the level of classification may vary from a clinician to another. However, 
when it is too detail, it became unpopular as it purposed a clinical burden to remember 
the scoring systems. In the previous studies, Salzman and Hirsh predictive models were 
used in risk stratifying their patients (Salzman and Hirsh, 1994; Tun et al., 2004. 
However, it lacks details and the stratification may occasionally become a subjective 
overview of the patient’s risk. There are two widely adapted detailed risk assessment 
models – Rogers’ Risk Assessment Model from the Patient Safety in Surgery Study and 
Caprini Risk Assessment Model (Gould et al., 2012). In my study, I choose to use 
Caprini Risk Assessment Model as it is more clinician friendly and it is not as detailed 
as the Rogers’ Risk Assessment Model. The aim of this study is to see whether the 
12 
 
Caprini Risk Assessment Model in relationship to asymptomatic DVT. All the subjects 
of the study will be risk stratified according to Caprini Risk Assessment Model and 
classify them to low, moderate, high and highest risks. Based on the Risk Assessment 
Model, the comparison made to see the group and the presence of silent deep vein 
thrombosis via ultrasound duplex of the venous system. If this should be a negative 
finding, I would look at the risk score from the model in proportion to the patient being 
scanned. 
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CHAPTER THREE 
OBJECTIVES 
3.1 GENERAL OBJECTIVES 
To determine the incidence of silent deep vein thrombosis (DVT) and validate the utility 
of Caprini’s risk assessment model in identifying those who are in need of DVT 
prophylaxis . 
3.2 SPECIFIC OBJECTIVES 
1) To determine the incidence of silent deep vein thrombosis in post operative surgical 
patients at HUSM. 
2) To determine the association between the use of DVT prophylaxis and the Caprini 
risk score groups. 
3.3 RESEARCH QUESTIONS? 
1) What is the incidence of silent deep vein thrombosis among post operative surgical 
patients at HUSM? 
2) Is there any significant association between the use of DVT prophylaxis and Caprini 
risk score groups? 
3.4 RESEARCH HYPOTHESES 
1) Null hypothesis:  The incidence of silent deep vein thrombosis is 2.2% ( Tun et al.  
2004) 
Alternative hypothesis: The incidence of silent deep vein thrombosis is more or less 
than 2.2% (two-sided hypothesis) 
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2) Null hypothesis: There is no significant association between the use of DVT 
prophylaxis and Caprini risk score groups. 
Alternative hypothesis: There is a significant association between the use of DVT 
prophylaxis and Caprini risk score groups. 
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CHAPTER FOUR 
METHODOLOGY 
4.1 STUDY DESIGN AND PERIOD OF THE STUDY 
This is a prospective cohort study involving post operative HUSM surgical patients who 
are at risk of developing silent DVT. This study was conducted from December 2013 
until May 2014 for a total period of 6 months.  
 
4.2 STUDY AREA 
This study was performed at the General Surgical Wards of HUSM, a main centre of 
referral for surgical patients who are in need of specialized surgical care. On the 
average, this centre received 1080 surgical patients per annum (90 subjects / month). 
The number of potential subjects who are at high risk of silent DVT is estimated at 80 
cases per month. 
 
4.3 REFERENCE POPULATION 
All general surgical subjects who are at high risk of postoperative silent DVT in 
Kelantan 
 
4.4 SOURCE POPULATION 
All general surgical subjects who are at high risk of postoperative silent DVT and 
hospitalized at HUSM, Kubang Kerian, Kelantan. 
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4.6 SAMPLING FRAME 
General surgical subjects who have fulfilled inclusion and exclusion criteria and 
undergone surgical treatment in the surgical wards of HUSM, Kubang Kerian, 
Kelantan. 
 
4.7 STUDY PARTICIPANTS 
All surgical subjects who have met the prerequisites selections as mentioned above and 
consented to study participation. 
 
4.8 INCLUSION AND EXCLUSION CRITERIA 
4.8.1 Inclusion criteria 
All the subjects are aged 18 and above, who underwent surgical operations involving 
general or regional anaesthesia for more than 45 minutes and has consented to 
participate in the study. 
4.8.2 Exclusion criteria 
Any subjects who were already diagnosed or on treatment for any form of venous 
thromboembolism and those who meet the inclusion criteria but refused to participate in 
the study for whatsoever reasons. 
 
 
 
17 
 
4.9 SAMPLING METHOD 
Convenient sampling method was chosen due to the scarcity of potential study 
participants secondary to last-minute cancellation of the planned surgical procedures 
and for not fulfilling the inclusion and exclusion criteria of this study. 
 
4.10 SAMPLE SIZE CALCULATION 
Sample size was calculated using single proportion formula for the first 
objective and Power and Sample Size (PS) software version 3.0.4.3 (Vanderbilt 
University, Nashville, Tennessee, USA; 2011) for objective 2. For objective 1, two 
estimates of the incidence of silent DVT were used, which were based on the studies by 
Tun et al.  (2004) and Harris et al. (1997). Based on these two estimates, the calculated 
sample size for objective 1 will be as follows: 
Objective 1: Incidence of silent DVT in postoperative surgical patients (using 
estimates from Harris et al. (1997) ) 
n=  � 𝑧�2p(1- p) 
z =1.96 
= precision =0.06 
p = Incidence of silent DVT = 7.5% (Harris et al. 1996) 
n = (1.96/0.06)2 0.075(1-0.075) 
n = 74 subjects 
18 
 
Drop out rates = 10% 
nfinal = 82 subjects 
 
Objective 1: Incidence of silent DVT in postoperative surgical patients (using 
estimates from Tun et al. (2004) ) 
n=  � 𝑧�2p(1- p) 
z =1.96 
= precision =0.05 
p = Incidence of silent DVT = 2.2% (Tun et al.  2004) 
n = (1.96/0.05)2 0.022(1-0.022) 
n = 33 subjects 
Drop out rates = 10% 
nfinal = 37 subjects 
For this objective, the sample size calculated using the estimate from Tun et al. (2004) 
was chosen since it was based on local estimate of silent DVT, which reflects the 
number of new cases of silent DVT encountered during the day-to-day surgical practice 
in HUSM. 
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Objective 2: The association between the use of DVT prophylaxis and Caprini risk 
score. 
For this objective, the sample size was calculated using the parameter estimate obtained 
from Bahl et al. (2009) for Po (the prevalence of DVT prophylaxis in Caprini low risk 
group (4 or less) ). For P1  (the prevalence of DVT prophylaxis in the Caprini high risk 
group (Caprini score >4) is set at 0.01 based on expert opinion. Therefore the calculated 
sample size was as follows: 
α (Type I error rate, level of significance) = 0.05 
Power of the study (1-β) = 0.80 
P0 = 0.01 (clinical expert opinion) 
P1 = 0.32 (Bahl et al. 2009) 
m = ratio of controls to cases = 1 
n = 21 subjects per group 
Attrition rate = 10% 
Total number of subjects needed = [21 + 21(10) ] x 2 
nfinal = 48 subjects (24 per group). 
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4.11 STUDY PROTOCOLS AND OPERATIONAL DEFINITIONS 
4.11.1 Study protocols 
The subjects who were consented to participate in the study will first be risk 
stratified according to the Thrombosis Risks Factor Scoring system proposed by Caprini 
and Arcelus (2006).Each subject who consented to participate in the study had a pre-
operative duplex ultrasound of the deep venous system of bilateral lower limbs and 
followed by a post-operative ultrasound duplex of the deep venous system of bilateral 
lower limbs on post operative day four. 
For the purpose of perfoming venous ultrasonograph,  Siemens Acuson X300 
Premier Edition ultrasound machine (Siemens, Washington DC, USA) was used. Two 
different radiologists were tasked to perform the ultrasound to ensure the reliability of 
the results. The ultrasonography of bilateral lower extremities was performed with 
colour flow duplex imaging of the major veins including the common femoral, 
superficial femoral and popliteal veins. Thrombi present in these veins were recorded as 
deep vein thrombosis. Ultrasound probes of various frequencies were selected to 
optimize imaging according to the patient’s body habitus. The routine used probes are 
the linear probes of 9-3MHz or curved probes of 5-2MHz. The compressibility is 
evaluated at 1cm intervals. This examination is then repeated with duplex ultrasound of 
the venous system to look for any other evidence of abnormal flow. The diagnosis of 
deep vein thrombosis is deemed present when the venous segment was not fully 
compressible, the presence of thrombus in the vein, absence of flow or abnormal flow. 
The inter-rater agreement of the results were excellent (Cohen’s kappa =1 (95% CI of 
kappa (not applicable). 
 
21 
 
4.11.2 Operational definitions 
Table 4.1 : Operational definitions of variables used in this study 
Risk factors Operational definitions 
(references) 
SPSS codings 
 
Age  Age of study participants 
at the time of inclusion 
into the study 
  Recorded as continuous variable  
Gender  Male and female  0 = female 
1 = male  
Ethnicity  
 
The race of subjects 
included in this study  
0 =Malays 
1 = Non-malays  
 
 
BMI  BMI = kg/(m)2 (WHO 
2004) 
0 = High 
1= Low 
 
Use of central 
venous catheter  
The use of central venous 
catheter during the 
surgical admission 
0 = No 
1 = Yes  
Types of central 
venous catheter  
The location where the 
CVC was placed 
0 = Nil 
1 = Internal Jugular Vein 
2 = Femoral vein 
3 = Subclavian vein 
 
  
DVT prophylaxis The use of any form of 
DVT prophylaxis during 
the hospitalization for 
surgery 
 
0 = No 
1 = Yes 
 
 
Types of DVT 
prophylaxis 
 
 
The types of DVT 
prophylaxis used during 
the period of 
hospitalization  
0 = Nil 
1 = Pneumatic calf compression 
2= Thromboembolic deterrent 
stocking 
3 = Subcutaneous Heparin 
4 = Fundaparinux 
5 = Combined modes 
 
Silent DVT The presence of venous 
thrombosis in the limb of 
an asymptomatic patients  
(Pennell , Mantese  and 
Westfall 2008) 
0 = Not present 
1 = Present 
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4.12 ETHICAL ISSUES 
Since this study involves direct contact with human subjects, it thus requires 
ethical approval from the local ethical review board. An ethical clearance was obtained 
from USM Human Research Ethics Committee on 10th February 2014; FWA 
Registration Number 00007718 and IRB Registration Number 00004494. Moreover, the 
whole principles of ethics on human research as laid down by the Declaration of 
Helsinki (18th World Medical Association General Assembly, 1964) was thoroughly 
followed during the conduction of this study.  
Voluntary written informed consent was obtained from each participant of the 
study. Their rights to withdraw from the study at any stage and for any reason without 
jeopardizing their subsequent medical care were adequately informed to them. The 
confidentiality of information on each subject was preserved by not documenting the 
patient’s name or any other forms of identification on the data collection sheet. Each 
subject was given a random number and only the study investigator knew how to break 
the random code. Besides, the data collection sheet were kept by the principal 
investigator at a secure place and the SPSS file, in which all the information was stored, 
was password-protected to prevent any accidental or intentional breach of participant’s 
confidentiality. 
 
4.13 STATISTICAL ANALYSES 
Data analyses were performed using IBM Statistical Package for Social Sciences 
(SPSS) version 20 (IBM Corp. Released 2011. IBM SPSS Statistics for Windows, 
Version 20.0. Armonk, NY: IBM Corp ) and STATA version 11 ( StataCorp. 2009. 
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Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.). Simple 
linear and logistic regression analyses were used for the purpose of analyses. 
The data was firstly inspected for any inaccuracies and missing values. Any 
subject who is missing of more than 20% of the data was excluded from the analyses. 
No remedial measures for missing data were performed due to the unavailability of the 
SPSS add-on required for the execution of such statistical procedures. 
The data was then descriptively analysed in mean and percentage or median and 
interquartile range for continuous data, whilst for categorical data, frequency and 
percentage were used. The nonparametric Kruskall-Wallis test was then used to 
compared the differences in the outcome variable (Caprini risk score) between factors 
which have more than groups (eg types of DVT prophylaxis, choice of central venous 
catheter used). Besides that, simple logistic and linear regression analyses were 
employed to obtain the model that is accurately predictive of DVT prophylaxis (using 
Caprini risk score groups, CVA as the predictors, age, gender ethnicity and BMI ) and 
Caprini risk scores (the same predictors used). The nominal level of significance were 
set at the nominal 0.05 (two sided) and any p value that is less than this threshold is 
considered to be statistically significant. 
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CHAPTER FIVE 
RESULTS 
5.1 GENERAL FEATURES OF THE STUDY SUBJECTS 
 In total, 55 subjects were included in the study. The mean age of the study 
participants was 51.3 years (SD 15.18). More females were recruited than males (54.5% 
vs 45.5%), but nevertheless the ratio between the gender was still maintained at 1:1. The 
study sample was predominantly composed of individuals of Malay ethnicity whilst 
only 5% of study samples were of Chinese (94.5% vs 5.5%). Nearly two third of the 
subjects did not use any form of central venous access (63.6%) whilst among those who 
have it, internal jugular vein (IJV) catheter placement was the main type of central 
venous access (80%). 
  With respect to DVT prophylaxis, more than three fourth (76.5%) of the 
subjects did not receive any mode of DVT prevention. Among those who received it, 
thromboembolic deterrent stocking was the main form of DVT prophylaxis (46.2%). 
Apart from that, the mean body mass index (BMI) of the study participants was 25.7 
(SD 4.62). 
 In regard to Caprini risk assessment score for venous thromboembolism (VTE), 
the mean score was 6.0 (SD 2.72).  The range of the Caprini score recorded from the 
study participants is from 3 to 13. More than two thirds of study participants belonged 
to the high Caprini risk score group (Caprini score more than 4). Further information is 
presented in Table 5.1: 
 
 
